1. Home
  2. ACIU vs EWCZ Comparison

ACIU vs EWCZ Comparison

Compare ACIU & EWCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACIU
  • EWCZ
  • Stock Information
  • Founded
  • ACIU 2003
  • EWCZ 2004
  • Country
  • ACIU Switzerland
  • EWCZ United States
  • Employees
  • ACIU N/A
  • EWCZ N/A
  • Industry
  • ACIU Biotechnology: Pharmaceutical Preparations
  • EWCZ Package Goods/Cosmetics
  • Sector
  • ACIU Health Care
  • EWCZ Consumer Discretionary
  • Exchange
  • ACIU Nasdaq
  • EWCZ Nasdaq
  • Market Cap
  • ACIU 332.4M
  • EWCZ 283.8M
  • IPO Year
  • ACIU 2016
  • EWCZ 2021
  • Fundamental
  • Price
  • ACIU $3.18
  • EWCZ $6.46
  • Analyst Decision
  • ACIU Strong Buy
  • EWCZ Buy
  • Analyst Count
  • ACIU 2
  • EWCZ 7
  • Target Price
  • ACIU $12.00
  • EWCZ $7.64
  • AVG Volume (30 Days)
  • ACIU 146.5K
  • EWCZ 1.4M
  • Earning Date
  • ACIU 11-05-2024
  • EWCZ 11-14-2024
  • Dividend Yield
  • ACIU N/A
  • EWCZ N/A
  • EPS Growth
  • ACIU N/A
  • EWCZ 62.57
  • EPS
  • ACIU N/A
  • EWCZ 0.23
  • Revenue
  • ACIU $48,505,404.00
  • EWCZ $223,500,000.00
  • Revenue This Year
  • ACIU $85.33
  • EWCZ $1.02
  • Revenue Next Year
  • ACIU $80.69
  • EWCZ $2.37
  • P/E Ratio
  • ACIU N/A
  • EWCZ $28.06
  • Revenue Growth
  • ACIU 4097200.00
  • EWCZ 2.42
  • 52 Week Low
  • ACIU $2.25
  • EWCZ $4.80
  • 52 Week High
  • ACIU $5.14
  • EWCZ $16.07
  • Technical
  • Relative Strength Index (RSI)
  • ACIU 47.00
  • EWCZ 49.19
  • Support Level
  • ACIU $3.10
  • EWCZ $5.64
  • Resistance Level
  • ACIU $3.48
  • EWCZ $6.61
  • Average True Range (ATR)
  • ACIU 0.17
  • EWCZ 0.46
  • MACD
  • ACIU -0.01
  • EWCZ 0.03
  • Stochastic Oscillator
  • ACIU 17.78
  • EWCZ 87.80

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

About EWCZ European Wax Center Inc.

European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax.

Share on Social Networks: